RMTI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

16.55M

-32.91%

-0.040

+100%

17.75M

-6.16%

-0.035

-12.5%

17.87M

+11.19%

-0.030

-40%

Estimates Revision

The market is revising Downward the revenue expectations for Rockwell Medical, Inc. (RMTI) for FY2025, with the revenue forecasts being adjusted by -1.51% over the past three months. During the same period, the stock price has changed by -14.77%.

Revenue Estimates for FY2025

Revise Downward

-1.51%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-2.78%

In Past 3 Month

Stock Price

Go Down

-14.77%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast RMTI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RMTI is 3.75 USD with a low forecast of 2.50 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

2.50

Averages

3.75

High

5.00

Current: 0.000

Low

2.50

Averages

3.75

High

5.00

H.C. Wainwright

Buy

downgrade

2025-11-13

Reason

H.C. Wainwright

Price Target

2025-11-13

downgrade

Buy

Reason

H.C. Wainwright lowered the firm's price target on Rockwell Medical to $2.50 from $3 and keeps a Buy rating on the shares after the company reported a "slight" top-line miss in Q3. The firm, which has adjusted its long-term forecasts, tells investors that the company's revenue base, while "meaningfully more diversified" than in the past, may not benefit from large contracts as much as in the past.

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Maintains

$7 → $3

2025-03-24

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$7 → $3

2025-03-24

Maintains

Strong Buy

Reason

Valuation Metrics

The current forward P/E ratio for Rockwell Medical Inc (RMTI.O) is -6.91, compared to its 5-year average forward P/E of -0.15. For a more detailed relative valuation and DCF analysis to assess Rockwell Medical Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-0.15

Current PE

-6.91

Overvalued PE

63.05

Undervalued PE

-63.35

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-19.90

Current EV/EBITDA

-300.47

Overvalued EV/EBITDA

66.96

Undervalued EV/EBITDA

-106.76

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.62

Current PS

0.48

Overvalued PS

1.02

Undervalued PS

0.23

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

RMTI News & Events

Events Timeline

No data

News

7.5

01-05Newsfilter

Rockwell Medical Extends Product Purchase Agreement Through 2026

5.0

2025-11-18Newsfilter

Rockwell Medical Names Joe Dawson to Its Board of Directors

9.5

2025-11-12SeekingAlpha

Rockwell Medical Reports Non-GAAP EPS of $0.00 and Revenue of $15.93M, Falling Short by $0.31M; Maintains Full-Year Guidance

People Also Watch

Frequently Asked Questions

What is Rockwell Medical Inc (RMTI) stock price today?

The current price of RMTI is 0.9375 USD — it has decreased -4.09 % in the last trading day.

What is Rockwell Medical Inc (RMTI)'s business?

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

What is the price predicton of RMTI Stock?

What is Rockwell Medical Inc (RMTI)'s revenue for the last quarter?

Rockwell Medical Inc revenue for the last quarter amounts to 15.93M USD, decreased -43.75 % YoY.

What is Rockwell Medical Inc (RMTI)'s earnings per share (EPS) for the last quarter?

Rockwell Medical Inc. EPS for the last quarter amounts to -0.05 USD, decreased -225.00 % YoY.

What changes have occurred in the market's expectations for Rockwell Medical Inc (RMTI)'s fundamentals?

How many employees does Rockwell Medical Inc (RMTI). have?

Rockwell Medical Inc (RMTI) has 244 emplpoyees as of January 10 2026.

What is Rockwell Medical Inc (RMTI) market cap?

Today RMTI has the market capitalization of 36.94M USD.